# Macular Edema Nepafenac vs. Difluprednate Uveitis Trial

> **NCT01939691** · PHASE4 · TERMINATED · sponsor: **University of California, San Francisco** · enrollment: 9 (actual)

## Conditions studied

- Uveitis
- Macular Edema

## Interventions

- **DRUG:** Difluprednate
- **DRUG:** Nepafenac
- **DRUG:** Prednisolone acetate

## Key facts

- **NCT ID:** NCT01939691
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-09-12
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-03-31
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Difficulty enrolling
- **Last updated:** 2021-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01939691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01939691, "Macular Edema Nepafenac vs. Difluprednate Uveitis Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01939691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*